Adam FeuersteinVerified account @adamfeuerstein
FollowFollow @adamfeuerstein
More
$CNAT CEO: "The emricasan study in NASH failed but we will push ahead anyway because in six months, no one will remember and some idiot will buy our stock o...查看全文
greenlandbiotech2019-03-07 03:28
尽管我们3月重点推荐的PRTO结果还没有出来(下周一可能公布结果,因此已经出现run up),但是我们现在期望可以给大家提前埋伏的机会,所以早早的就准备好了这份下个季度重点关注的对象清单,这次我们依然选择了三个公司,并且其中2个公司是NASH市场的玩家($中大制药(CNAT)$ 和$Cymabay Therapeuti...查看全文
希望在明天了2018-12-29 05:00
$中大制药(CNAT)$ 下礼拜,如果能随大盘调整而下探,将是一个非常好的入场机会。但要控制好仓位。
原则上不参与其他非生化类股票的做多,等待大盘调整到位再考虑。查看全文
shendong20002018-11-10 09:37
$Conatus Pharmaceuticals Inc. (CNAT)$ 该股在4月的时候就干过类似的事情。大幅拉高后,派发,出利空大幅杀跌。估计这回干同样的事。
个人观察:大部分生化股,只有药被F D A通过了,才有一波大行情,如果仅仅是某阶段数据好,就是一个打鸡血的行情。各位朋友要及时获利了结。不要盲目赌数据...查看全文
$Conatus Pharmaceuticals Inc.(CNAT)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-02 AccNo: 0001564590-18-018892 Size: 4 MB 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-08-02 AccNo: 0001193125-18-236596 Size: 322 KB 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ 8-K - Current report Filed: 2018-08-01 AccNo: 0001171843-18-005617 Size: 71 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-07-10 AccNo: 0000215457-18-005869 Size: 12 KB 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ 8-K - Current report Filed: 2018-06-25 AccNo: 0001171843-18-004815 Size: 24 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ 内部交易: 2018-05-04,总裁, CEO & Director,Mento Steven J ,期权,60000普通股, $0.99
$Conatus Pharmaceuticals Inc.(CNAT)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-03 AccNo: 0001564590-18-010665 Size: 3 MB 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ 8-K - Current report Filed: 2018-05-02 AccNo: 0001171843-18-003332 Size: 56 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001193125-18-139072 Size: 796 KB 网页链接
$Conatus Pharmaceuticals Inc.(CNAT)$ 美东时间 2018-05-02 盘后 披露财报,预期EPS -0.17 网页链接